Clinical Trials
2 trialsNCT07472153 2026-05-28
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre
Phase 2/3 Recruiting
NCT03238261 2017-08-11
Chemotherapy / Radiotherapy in Uterine Cervical Neoplasms
Instituto Nacional de Cancerologia, Columbia
Phase NA Completed